These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4173212)

  • 1. [Immunologic study of human prothrombin and thrombin].
    Josso F; Lavergne JM; Weilland C; Soulier JP
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):311-24. PubMed ID: 4173212
    [No Abstract]   [Full Text] [Related]  

  • 2. The purification of human factor II (prothrombin) and the preparation of a specific antiserum.
    Heystek J; Maier van den Zande GM; Brummelhuis HG; Krijnen HW
    Vox Sang; 1974; 27(3):214-26. PubMed ID: 4213473
    [No Abstract]   [Full Text] [Related]  

  • 3. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
    Pechet L; Smith JA
    Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease.
    Largo R; Sigg P; von Felten A; Straub PW
    Br J Haematol; 1974 Jan; 26(1):129-40. PubMed ID: 4211775
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization and experimental use of a monospecific antiserum to factor IX.
    Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tentative immunochemical analysis of the prothrombin molecule.
    Lavergne JM; Weilland C; Josso F
    Pathol Biol (Paris); 1972 Dec; ():Suppl:47-51. PubMed ID: 4122342
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona.
    Josso F; Monasterio de Sanchez J; Lavergne JM; Menache D; Soulier JP
    Blood; 1971 Jul; 38(1):9-16. PubMed ID: 4997605
    [No Abstract]   [Full Text] [Related]  

  • 8. Human coumarin prothrombin. Chromatographic, coagulation and immunologic studies.
    Cesbron N; Boyer C; Guillin MC; Ménaché D
    Thromb Diath Haemorrh; 1973 Dec; 30(3):437-50. PubMed ID: 4207085
    [No Abstract]   [Full Text] [Related]  

  • 9. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood].
    Kotschy M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):426-36. PubMed ID: 4121336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor X. Immunological studies.
    Prydz H; Gladhaug A
    Thromb Diath Haemorrh; 1971; 25(1):157-65. PubMed ID: 4325293
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
    Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin level and activity in the abnormal factor X (factor X Friuli) hemorrhagic disorder.
    Girolami A; Sticchi A; Brunetti A
    Thromb Diath Haemorrh; 1971; 25(1):147-56. PubMed ID: 4996074
    [No Abstract]   [Full Text] [Related]  

  • 15. [The nature of serum factor precipitating autologous alpha-globulins in rabbits].
    Krutitskaia LI; Polosatov MV
    Biull Eksp Biol Med; 1988 Sep; 106(9):331-4. PubMed ID: 2458777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency and limits of immunologic methods in the diagnosis of blood coagulation].
    Schwick HG; Trobisch H; Heimburger N
    Internist (Berl); 1973 Apr; 14(4):160-9. PubMed ID: 4197663
    [No Abstract]   [Full Text] [Related]  

  • 17. [The physiology of blood platelets].
    Lüscher EF
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1629-35. PubMed ID: 5698340
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic properties of factor IX (Christmas factor).
    Uszyński L
    Arch Immunol Ther Exp (Warsz); 1969; 17(3):320-31. PubMed ID: 5802831
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
    Pechet L; Groth CG; Daloze PM
    J Lab Clin Med; 1969 Jan; 73(1):91-102. PubMed ID: 4883102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.